|Selected news articles which highlight important policy issues.||
News: Weekly Archives
News for the week of 05-19-2006
FDA panel backs key STD vaccine; Medical community hails 'breakthrough' in cervical cancer fight
Amidst an ongoing flood of Vioxx litigation, Merck got some badly needed good newsand good pressthis week when an FDA advisory panel unanimously recommended approval for its new cervical cancer vaccine. Merck's vaccine could slash cervical cancer rates around the world, particularly in developing nations where there is little access to routine gynecological care.
In a major advance for women's health, a Food and Drug Administration advisory panel recommended Thursday that the agency approve a new vaccine against a sexually transmitted virus that causes cervical cancer. The unanimous recommendation inspired cheers from the medical community, which said the vaccine could help save the lives of tens of thousands of women worldwide.
|home spotlight commentary research events news about contact links archives|